Medicare Group Q.P.S.C. (QSE:MCGS)
5.31
-0.19 (-3.37%)
At close: Feb 26, 2026
Medicare Group Q.P.S.C. Revenue
In the year 2025, Medicare Group Q.P.S.C. had annual revenue of 502.60M QAR, down -3.99%. Medicare Group Q.P.S.C. had revenue of 126.49M in the quarter ending December 31, 2025, a decrease of -10.33%.
Revenue
502.60M
Revenue Growth
-3.99%
P/S Ratio
2.97
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 502.60M | -20.89M | -3.99% |
| Dec 31, 2024 | 523.49M | 37.54M | 7.72% |
| Dec 31, 2023 | 485.96M | -1.21M | -0.25% |
| Dec 31, 2022 | 487.17M | 3.54M | 0.73% |
| Dec 31, 2021 | 483.63M | 6.83M | 1.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Revenue RankingsMedicare Group Q.P.S.C. News
- 1 day ago - Medicare will run out of money 12 years earlier than expected - MarketWatch
- 3 days ago - Ozempic Price War - Novo Nordisk Slashes Prices By 50% - Benzinga
- 11 days ago - The vital measure of senior health that Medicare ignores - The Washington Post
- 16 days ago - RFK Jr. shakes up leadership team - POLITICO
- 16 days ago - AbbVie files lawsuit over selection of Botox for Medicare price negotiations - Seeking Alpha
- 20 days ago - Oz alleges Maine 'looks a lot like Minnesota' regarding entitlement fraud - The Hill
- 23 days ago - NovoCure projects $13M monthly revenue hit as Medicare revokes billing privileges - Seeking Alpha
- 24 days ago - Novo Nordisk is being more cautious on Medicare, says Mizuho's Holz - CNBC